Semler Scientific Inc (SMLR) - Total Liabilities
Based on the latest financial reports, Semler Scientific Inc (SMLR) has total liabilities worth $136.93 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Semler Scientific Inc to see how much of total assets are deployed in long-term investments.
Semler Scientific Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how Semler Scientific Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Semler Scientific Inc assets under control.
Semler Scientific Inc Competitors by Total Liabilities
The table below lists competitors of Semler Scientific Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Lidao New Material Co Ltd Class A
SHG:603937
|
China | CN¥1.02 Billion |
|
Advanced Enzyme Technologies Limited
NSE:ADVENZYMES
|
India | Rs1.56 Billion |
|
The Star Entertainment Group Limited
F:EE9
|
Germany | €1.07 Billion |
|
Mayur Uniquoters Ltd
NSE:MAYURUNIQ
|
India | Rs1.16 Billion |
|
ON24 Inc
NYSE:ONTF
|
USA | $88.91 Million |
|
EDREAMS ODIGEO UNS.ADR/10
F:K0I
|
Germany | €860.06 Million |
|
Fujian Yuanxiang New Materials Co. Ltd. A
SHE:301300
|
China | CN¥132.04 Million |
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
USA | $97.61 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Semler Scientific Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Semler Scientific Inc (SMLR) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Semler Scientific Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Semler Scientific Inc (2011–2024)
The table below shows the annual total liabilities of Semler Scientific Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.08 Million | +44.78% |
| 2023-12-31 | $6.27 Million | -10.65% |
| 2022-12-31 | $7.02 Million | +36.92% |
| 2021-12-31 | $5.12 Million | +5.76% |
| 2020-12-31 | $4.85 Million | -7.06% |
| 2019-12-31 | $5.21 Million | +48.00% |
| 2018-12-31 | $3.52 Million | -48.35% |
| 2017-12-31 | $6.82 Million | +13.85% |
| 2016-12-31 | $5.99 Million | +44.33% |
| 2015-12-31 | $4.15 Million | +2.14% |
| 2014-12-31 | $4.06 Million | +101.29% |
| 2013-12-31 | $2.02 Million | -60.03% |
| 2012-12-31 | $5.05 Million | +341.91% |
| 2011-12-31 | $1.14 Million | -- |
About Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more